Most types of breast cancer produce similar symptoms and are discovered the same way—finding a strange new lump during a self-exam, or a healthcare provider spotting something suspicious during a ...
Pyrotinib in the first-line treatment of HER2-positive advanced breast cancer: Results from the PRETTY study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Normally, HER2 helps your healthy breast cells grow and divide. But too much HER2 can trigger cells to grow out of control. HER2-positive breast cancer happens when the HER2 gene in your DNA mutates ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III INAVO120 study of the ...
HR-positive/HER-negative breast cancer is the most common breast cancer diagnosis. Although it occurs more frequently in white women, women of color experience ...
HER2 — which stands for human epidermal growth factor receptor 2 — is a type of protein that causes cancer cells to grow more quickly. Tumors that are HER2-positive have higher levels of the HER2 ...
The novel oral selective estrogen receptor (ER) degrader giredestrant significantly reduced the risk of invasive disease ...
The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the ...
Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company (the Company), has been notified by the U.S. Food and Drug Administration (FDA) that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results